Authors
José A Joglar, Mina K Chung, Anastasia L Armbruster, Emelia J Benjamin, Janice Y Chyou, Edmond M Cronin, Anita Deswal, Lee L Eckhardt, Zachary D Goldberger, Rakesh Gopinathannair, Bulent Gorenek, Paul L Hess, Mark Hlatky, Gail Hogan, Chinwe Ibeh, Julia H Indik, Kazuhiko Kido, Fred Kusumoto, Mark S Link, Kathleen T Linta, Gregory M Marcus, Patrick M McCarthy, Nimesh Patel, Kristen K Patton, Marco V Perez, Jonathan P Piccini, Andrea M Russo, Prashanthan Sanders, Megan M Streur, Kevin L Thomas, Sabrina Times, James E Tisdale, Anne Marie Valente, David R Van Wagoner
Publication date
2024/1/2
Source
Circulation
Volume
149
Issue
1
Pages
e1-e156
Publisher
Lippincott Williams & Wilkins
Description
AIM
The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation” provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation.
METHODS
A comprehensive literature search was conducted from May 12, 2022, to November 3, 2022, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.
STRUCTURE
Atrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and …
Total citations
Scholar articles
JA Joglar, MK Chung, AL Armbruster, EJ Benjamin… - Circulation, 2024